Immunovant
Immunovant
World Rank (Jan-05-2024)
2,674
Market Cap (Jan-05-2024)
5.626 Billion USD
World Rank (Jul-30-2023)
4,418
Market Cap (Jul-30-2023)
2.942 Billion USD
World Rank (Jan-07-2022)
9,880
Market Cap (Jan-07-2022)
0.919 Billion USD
World Rank (Jan-01-2021)
3,187
Market Cap (Jan-01-2021)
4.522 Billion USD
Headquarters Country
Nasdaq / NYSE Code
IMVT
Market Cap (Mar-08-2026)
5.43
Employee Count
70
Employee Count as of Date
As on 2021
Headquarters City/State
World Region
World Subregion
Annual Revenue in USD
0 Million USD
Annual Net Income in USD
-156 Million USD
Annual Results for Period Ending
Mar-2022 ending year
Total Assets in USD
515 Million USD
Total Liabilities in USD
45 Million USD
Total Equity in USD
469 Million USD
Balance Sheet for Period Ending
Mar-2022 ending year
Business Sector
Company Website
Yahoo
Ads